Substituted Imidazopyrazine Compounds as Ligand Directed Degraders of IRAK3
US-2026028343-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Miao Guobin patents
Miao Guobin is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Miao Guobin |
| Total patents | 7 |
| First publication | Jun 1, 2023 |
| Latest publication | Jan 29, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterocyclic pad4 inhibitors
US-2025353848-A1 · Nov 20, 2025 · US
Heterocyclic PAD4 inhibitors
US-12473304-B2 · Nov 18, 2025 · US
Heterocyclic pad4 inhibitors
US-2025346592-A1 · Nov 13, 2025 · US
Tricyclic fused pyrimidine compounds for use as her2 inhibitors
US-2024391931-A1 · Nov 28, 2024 · US
Mk2 inhibitors and uses thereof
US-2024190890-A1 · Jun 13, 2024 · US
Heterocyclic pad4 inhibitors
US-2023167131-A1 · Jun 1, 2023 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bristol Myers Squibb Co | 4 |
| Celgene Corp | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| C07D519/00 | 5 |
| A61K31/5377 | 3 |
| C07D471/04 | 3 |
| A61P37/00 | 3 |